{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:45:17Z","timestamp":1762429517304,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002905","name":"Ministerio de Salud y Protecci\u00f3n Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002905","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.vhri.2023.06.005","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T11:59:29Z","timestamp":1691755169000},"page":"61-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia"],"prefix":"10.1016","volume":"38","author":[{"given":"Camilo","family":"Tamayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Huertas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daysi","family":"Sanmartin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lica","family":"Ord\u00f3\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fern\u00e1n","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vhri.2023.06.005_bib1","article-title":"Survival outcomes after heart transplantation","volume":"12","author":"Moayedi","year":"2019","journal-title":"Circ Hear Fail"},{"issue":"2","key":"10.1016\/j.vhri.2023.06.005_bib2","first-page":"91","article-title":"Trasplante card\u00edaco","volume":"18","author":"L\u00e1zaro","year":"2011","journal-title":"Cir Cardiovasc"},{"issue":"10","key":"10.1016\/j.vhri.2023.06.005_bib3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0300-8932(99)75010-4","article-title":"Gu\u00edas de actuaci\u00f3n cl\u00ednica de la Sociedad Espa\u00f1ola de Cardiolog\u00eda. Trasplante card\u00edaco y de coraz\u00f3n-pulmones","volume":"52","author":"Alonso-Pulp\u00f3n","year":"1999","journal-title":"Rev Espa\u00f1ola Cardiol"},{"issue":"9","key":"10.1016\/j.vhri.2023.06.005_bib4","first-page":"148","article-title":"Influence of acute rejection episodes, HLA matching, and donor\/recipient phenotype on the development of \u201cearly\u201d transplant-associated coronary artery disease","volume":"96","author":"Hornick","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.vhri.2023.06.005_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00001573-200403000-00018","article-title":"Biopsy-negative cardiac transplant rejection: etiology, diagnosis, and therapy","volume":"19","author":"Fishbein","year":"2004","journal-title":"Curr Opin Cardiol"},{"issue":"24","key":"10.1016\/j.vhri.2023.06.005_bib6","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1161\/01.CIR.0000149745.83186.89","article-title":"Drug therapy in the heart transplant recipient","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.vhri.2023.06.005_bib8","first-page":"s12","article-title":"An overview of immunosuppression in solid organ transplantation","volume":"21","author":"Enderby","year":"2015","journal-title":"Am J Manag Care"},{"issue":"4","key":"10.1016\/j.vhri.2023.06.005_bib9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01.TP.0000129814.52456.25","article-title":"Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients?","volume":"78","author":"Meiser","year":"2004","journal-title":"Transplantation"},{"issue":"1-2","key":"10.1016\/j.vhri.2023.06.005_bib10","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0041-1345(00)02611-7","article-title":"A\u00a0randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients","volume":"33","author":"Mehra","year":"2001","journal-title":"Transplant Proc"},{"issue":"8","key":"10.1016\/j.vhri.2023.06.005_bib11","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.transproceed.2004.08.059","article-title":"Efficacy and safety of tacrolimus versus cyclosporine microemulsion in primary cardiac transplant recipients: 6-month results in Taiwan","volume":"36","author":"Wang","year":"2004","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.vhri.2023.06.005_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2005.11.452","article-title":"Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J\u00a0Hear Lung Transplant"},{"issue":"4","key":"10.1016\/j.vhri.2023.06.005_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/TP.0b013e318277e378","article-title":"Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine A in combination with mycophenolate mofetil after heart transplantation","volume":"95","author":"Guethoff","year":"2013","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.vhri.2023.06.005_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","article-title":"Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients--a large European trial","volume":"6","author":"Grimm","year":"2006","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.vhri.2023.06.005_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1399-0012.2010.01309.x","article-title":"A\u00a0prospective randomized study comparing cyclosporine versus tacrolimus combined with daclizumab, mycophenolate mofetil, and steroids in heart transplantation","volume":"25","author":"S\u00e1nchez-L\u00e1zaro","year":"2011","journal-title":"Clin Transpl"},{"author":"Filipovi\u0107-Pierucci","key":"10.1016\/j.vhri.2023.06.005_bib17"},{"year":"2012","series-title":"Evaluaci\u00f3n Econ\u00f3mica de Medicamentos y Tecnolog\u00edas Sanitarias","author":"Soto \u00c1lvarez","key":"10.1016\/j.vhri.2023.06.005_bib19"},{"key":"10.1016\/j.vhri.2023.06.005_bib20","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Sistema de Informaci\u00f3n de Precios de Medicamentos - SISMED. Accessed August 18, 2021."},{"key":"10.1016\/j.vhri.2023.06.005_bib21","unstructured":"Ministerio de Salud y Protecci\u00f3n Social. Base de Datos Para el Estudio de Suficiencia y de los Mecanismos de Ajuste del Riesgo Para el C\u00e1lculo de la Unidad de Pago por Capitaci\u00f3n, Recursos Para Garantizar la Financiaci\u00f3n de Tecnolog\u00edas y Servicios de Salud en los Reg\u00edmenes Contributivo y Subsidiado. Accessed August 24, 2021."},{"issue":"3","key":"10.1016\/j.vhri.2023.06.005_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/heapol\/czab146","article-title":"Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia","volume":"37","author":"Espinosa","year":"2022","journal-title":"Health Policy Plan"},{"issue":"10","key":"10.1016\/j.vhri.2023.06.005_bib29","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1016\/j.transproceed.2007.09.009","article-title":"Economic evaluation of everolimus and mycophenolate mofetil versus azathioprine in de novo heart transplantation","volume":"39","author":"Annemans","year":"2007","journal-title":"Transplant Proc"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109923000626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:14:32Z","timestamp":1761941672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109923000626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":20,"alternative-id":["S2212109923000626"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2023.06.005","relation":{},"ISSN":["2212-1099"],"issn-type":[{"type":"print","value":"2212-1099"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Tacrolimus Compared With Cyclosporine for Immunosuppression Therapy in Patients Who Underwent Heart Transplant in Colombia","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2023.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}